Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
Valentina Morena, Laura Milazzo, Letizia Oreni, Giovanna Bestetti, Tommaso Fossali, Cinzia Bassoli, Alessandro Torre, Maria Vittoria Cossu, Caterina Minari, Elisabetta Ballone, Andrea Perotti, Davide Mileto, Fosca Niero, Stefania Merli, Antonella Foschi, Stefania Vimercati, Giuliano Rizzardini, Salvatore Sollima, Lucia Bradanini, Laura Galimberti, Riccardo Colombo, Valeria Micheli, Cristina Negri, Anna Lisa Ridolfo, Luca Meroni, Massimo Galli, Spinello Antinori, Mario Corbellino
Topics & Concepts
TocilizumabMedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia2019-20 coronavirus outbreakViral pneumoniaVirologyBetacoronavirusIntensive care medicineInternal medicineOutbreakRheumatoid arthritisInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchRespiratory Support and Mechanisms